Vasculitis Trial, Recruiting (NCT06794827)

Vasculitis Trial, Recruiting NCT06794827 Sponsor: Leiden University Medical Center Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT06794827 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a condition called GPA (Granulomatosis with Polyangiitis) or MPA (Microscopic Polyangiitis), which are types of blood vessel inflammation diseases
You are being treated with, or are starting treatment with, a medication called avacopan
You agree to allow your medical information to be used for this study

Who may not be able to join:

You do not currently have active signs or measurable symptoms of your blood vessel disease (confirm with trial site)
You are under 16 years old

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Y.K. Onno Teng, Leiden University Medical Center

Phone: +31715262148

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06794827

Sponsor: Leiden University Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: +31715262148

More information: https://clinicaltrials.gov/study/NCT06794827

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a condition called GPA (Granulomatosis with Polyangiitis) or MPA (Microscopic Polyangiitis), which are types of blood vessel inflammation diseases
You are being treated with, or are starting treatment with, a medication called avacopan
You agree to allow your medical information to be used for this study

Who may not be able to join:

You do not currently have active signs or measurable symptoms of your blood vessel disease (confirm with trial site)
You are under 16 years old

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Leiden University Medical Center

Registry

ClinicalTrials.gov

Start date

1 November 2023

Est. completion

1 January 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Assess physician's treatment indications for starting avacopan as reported in the database questionnaire; Assess AAV patients' clinical characteristics at baseline as reported in the database questionnaire; Assess concomitant immunosuppressive treatment strategies employed with avacopan as registered in the database questionnaire; Assess the relevant clinical benefit of avacopan treatment at the individual patient level based on the BVAS score [0-63]

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov